HIV health care providers are ready to introduce pre-exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

Author:

Kowalska JD12ORCID,Bursa D13ORCID,Gökengin D4,Jilich D5,Tomazic J6,Vasylyev M7,Bukovinowa P8,Mulabdic V9,Antonyak S10,Horban A12,

Affiliation:

1. Department of Adults’ Infectious Diseases; Medical University of Warsaw; Warsaw Poland

2. Hospital for Infectious Diseases; HIV Out-Patient Clinic; Warsaw Poland

3. Hospital for Infectious Diseases; Warsaw Poland

4. Infectious Diseases and Clinical Microbiology; Ege University Medical Faculty; Izmir Turkey

5. Department of Infectious and Tropical Diseases; Hospital Na Bulovce; Prague Czech Republic

6. Department of Infectious Diseases; University Medical Center Ljubljana; Ljubljana Slovenia

7. Lviv Regional Public Health Center; Lviv Ukraine

8. Department of Infectious Diseases and Geographical Medicine; University Hospital; Bratislava Slovakia

9. Clinic for Infectious Diseases; Clinical Center of Sarajevo University; Sarajevo Bosnia and Herzegovina

10. Clinic of the Gromahevsky Institute of Epidemiology and Infectious Diseases; Kiev Ukraine

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference23 articles.

1. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV Geneva World Health Organization https://www.ncbi.nlm.nih.gov/books/NBK327115

2. European Medicines Agency First medicine for HIV pre-exposure prophylaxis recommended for approval in the EU. EMA/CHMP/496941/2016 http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2016/07/WC500210885.pdf

3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults;Clumeck;HIV Med,2008

4. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3